KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Treasury Shares: 2010-2025

Historic Treasury Shares for Regeneron Pharmaceuticals (REGN) over the last 12 years, with Sep 2025 value amounting to $17.9 billion.

  • Regeneron Pharmaceuticals' Treasury Shares rose 26.44% to $17.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 billion, marking a year-over-year increase of 26.44%. This contributed to the annual value of $15.2 billion for FY2024, which is 20.76% up from last year.
  • According to the latest figures from Q3 2025, Regeneron Pharmaceuticals' Treasury Shares is $32.7 million, which was up 3.48% from $31.6 million recorded in Q2 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Treasury Shares peaked at $32.7 million during Q3 2025, and registered a low of -$17.7 million during Q2 2021.
  • Moreover, its 3-year median value for Treasury Shares was $25.8 million (2024), whereas its average is $22.9 million.
  • Data for Regeneron Pharmaceuticals' Treasury Shares shows a peak YoY soared of 545.87% (in 2021) over the last 5 years.
  • Over the past 5 years, Regeneron Pharmaceuticals' Treasury Shares (Quarterly) stood at $8.3 billion in 2021, then rose by 25.33% to $10.4 billion in 2022, then increased by 21.32% to $12.6 billion in 2023, then climbed by 20.76% to $15.2 billion in 2024, then rose by 26.44% to $17.9 billion in 2025.
  • Its Treasury Shares was $17.9 billion in Q3 2025, compared to $17.3 billion in Q2 2025 and $16.2 billion in Q1 2025.